Search for: "NOVO NORDISK PHARMACEUTICALS, INC."
Results 1 - 20
of 88
Sort by Relevance
|
Sort by Date
6 May 2024, 8:26 am
The Federal Trade Commission (FTC) announced late last month that it had “expanded its campaign against pharmaceutical manufacturers’ improper or inaccurate listing of patents in the Food and Drug Administration’s (FDA) Orange Book, disputing junk patent listings for diabetes, weight loss, asthma, and COPD drugs, including Novo Nordisk Inc. [read post]
5 Mar 2024, 10:55 am
Since 2019, the following pharmaceutical manufacturers have posted seven or more notices of correction: Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Novo Nordisk, and Purdue Pharmaceuticals. [read post]
28 Feb 2023, 12:22 pm
During 2022, the Bernstein Litowitz firm was lead or co-lead counsel in cases with settlements over $100 million: the Luckin Coffee settlement ($175 million) and the Novo Nordisk settlement ($100 million). [read post]
9 Jan 2023, 9:01 pm
Walgreens After more than seven years of litigation, Walgreens, Inc. [read post]
5 Jan 2023, 2:22 pm
The settlement ranks among the five largest securities settlements ever paid by a pharmaceutical manufacturer. [read post]
9 Mar 2022, 2:06 pm
The largest 2021 settlements included one settlement in excess of $1 billion (the $1.21 billion settlement in the Valeant Pharmaceuticals International case) and four in excess of $100 million (Snap, Inc.: $187.5 million; DaVita, Inc.: $135 million; Allergan plc: $130 million; and GCI Liberty $110 million). [read post]
25 Jan 2022, 3:11 pm
There have already been several significant settlements that appear positioned for court approval in 2022, including Twitter ($809.5 million); Teva Pharmaceutical Industries ($420 million); Luckin Coffee ($175 million); Granite Construction ($129 million); Novo Nordisk A/S ($100 million); Stamps.com ($100 million) and NCI Building Systems, Inc. ($100 million). [read post]
5 Aug 2021, 12:12 pm
Novo Nordisk A/S, 566 U.S. 399, 406 (2012). [read post]
27 Jul 2020, 4:51 pm
Novo Nordisk, the First Circuit affirmed a district court judgment that prevented pharmaceutical company Novo Nordisk Inc. from enforcing a confidentiality and non-compete agreement that it had entered into with employee Thomas Russomano, who was briefly laid off and rehired before leaving the company for a competing company. [read post]
11 Jun 2020, 8:46 am
In January 2020, Russomano resigned from Novo Nordisk and accepted employment with a competitor, BioMarin Pharmaceutical, Inc. [read post]
17 Mar 2020, 1:32 pm
Eco-Gel 200 ultrasound gel has been recalled by Eco-Med Pharmaceutical, Inc. due to bacterial contamination. [read post]
1 Dec 2017, 11:35 am
Big pharma players such as Eli Lilly, Novo Nordisk and Allergan are committed to voluntary price restraints, while companies such as Novartis and Roche are in favor of value-based pricing. [read post]
15 Sep 2017, 4:33 am
Department of Justice (DOJ) announced pharmaceutical manufacturer Novo Nordisk Inc. has agreed to pay $58.65 million for failing to comply with a Food and Drug Administration (FDA) mandated Risk Evaluation and Mitigation Strategy (REMS) program. [read post]
11 Sep 2017, 12:30 pm
Pharmaceutical Manufacturer Novo Nordisk Inc. [read post]
14 Apr 2017, 1:10 pm
Novo Nordisk, Inc., 2011 WL 1085015 (S.C. [read post]
22 Oct 2015, 8:42 am
IMS Health, Inc., 131 S. [read post]
11 Mar 2015, 9:40 am
Novo Nordisk A/S, 132 S.Ct. 1670 (2012) (forcing correction of Orange Book listings) KSR has actually rocketed to the position of most-cited Supreme Court patent case of all time followed by Markman (1996); U.S. [read post]
14 Oct 2014, 5:29 am
See also Novo Nordisk A/S v. [read post]
28 Aug 2014, 5:09 pm
New Alzheimer's Drug Shows Promise It was of interest to note that commercials on CBS following the story included for Levemor (Novo Nordisk) and for Brisdelle (Noven, low dose paroxetine). [read post]
5 Mar 2014, 2:46 pm
Novo Nordisk, U.S. [read post]
